Detrimental graft survival of size-mismatched graft for high model for end-stage liver disease recipients in liver transplantation

被引:8
|
作者
Fukazawa, Kyota [1 ]
Nishida, Seigo [2 ,3 ]
Pretto, Ernesto A., Jr. [4 ]
Vater, Youri [1 ]
Reyes, Jorge D. [5 ]
机构
[1] Univ Washington, Div Transplantat, Dept Anesthesiol & Pain Med, Sch Med, 1959 NE Pacific St, Seattle, WA 98195 USA
[2] Univ Miami, Miller Sch Med, Div Liver & Gastrointestinal Transplant, Dept Surg, Miami, FL 33136 USA
[3] Jackson Mem Hosp, Miami, FL 33136 USA
[4] Univ Miami, Miller Sch Med, Div Solid Organ Transplantat, Dept Anesthesiol Perioperat Med & Pain Management, Miami, FL 33136 USA
[5] Univ Washington, Sch Med, Dept Surg, Div Transplantat, Seattle, WA 98195 USA
关键词
Body surface area; Liver transplant; Model for end-stage liver disease; Size mismatch; Survival; PORTAL VENOUS-PRESSURE; CLINICAL-IMPLICATIONS; BACTERIAL TRANSLOCATION; PORTACAVAL-SHUNT; WATER-RETENTION; VEIN PRESSURE; HEPATITIS-C; MELD SCORE; CIRRHOSIS; HYPERPERFUSION;
D O I
10.1002/jhbp.355
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundIn orthotopic liver transplantation (OLT) size-mismatch may cause adverse outcomes. We previously reported on a method to predict donor-recipient size-mismatch using the body surface area index (BSAi). In this study, we hypothesized that graft survival of size-mismatch transplantation deteriorates with higher model for end-stage liver disease (MELD) score at transplantation. MethodsWe evaluated non-parametrically the association of BSAi and MELD with 1-year graft survival with a generalized additive model. For derivation, transplantations performed between 2005 and 2010 were used. The associations were then validated by comparing Kaplan-Meier estimates between patient groups stratified according to estimated risk, using transplantations from 2011-2013. ResultsA total of 30,870 OLT were included in the study with 16,466 in the validation group. The derivation model revealed that graft survival significantly decreased with higher or lower BSAi, and with higher MELD (P < 0.0001). Validation confirmed the correlation of observed graft survival with estimated risk categories. ConclusionsWe found that there is an interactive effect between MELD score and size-mismatch. Also high MELD recipient has a narrower safety margin for size-mismatched graft. The risk calculated from our nonparametric model with MELD and BSAi well predicts outcome in liver transplantation.
引用
收藏
页码:406 / 413
页数:8
相关论文
共 50 条
  • [31] Factors Prognostic of Survival in Patients Awaiting Liver Transplantation for End-Stage Liver Disease
    Haldun Selcuk
    Irfan Uruc
    Mehtap Akcil Temel
    Serkan Ocal
    Bulent Huddam
    Murat Korkmaz
    Hakan Unal
    Mehmet Kanbay
    Nurten Savas
    Gurden Gur
    Ugur Yilmaz
    Mehmet Haberal
    Digestive Diseases and Sciences, 2007, 52 : 3217 - 3223
  • [32] Could tenofovir modify the model end-stage liver disease (MELD) score in patients with end-stage liver disease eligible for liver transplantation?
    Bruno, Raffaele
    Sacchi, Paolo
    Filice, Gaetano
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 (01) : 123 - 123
  • [33] High-dose hydroxocobalamin in end-stage liver disease and liver transplantation
    Sujit Vijay Sakpal
    Hannah Reedstrom
    Cody Ness
    Tobin Klinkhammer
    Hector Saucedo-Crespo
    Christopher Auvenshine
    Robert N. Santella
    Jeffery Steers
    Drugs & Therapy Perspectives, 2019, 35 : 442 - 446
  • [34] The combination of indocyanine green clearance test and model for end-stage liver disease score predicts early graft outcome after liver transplantation
    Tang Yunhua
    Ju Weiqiang
    Chen Maogen
    Yang Sai
    Zhang Zhiheng
    Wang Dongping
    Guo Zhiyong
    He Xiaoshun
    JOURNAL OF CLINICAL MONITORING AND COMPUTING, 2018, 32 (03) : 471 - 479
  • [35] The combination of indocyanine green clearance test and model for end-stage liver disease score predicts early graft outcome after liver transplantation
    Tang Yunhua
    Ju Weiqiang
    Chen Maogen
    Yang Sai
    Zhang Zhiheng
    Wang Dongping
    Guo Zhiyong
    He Xiaoshun
    Journal of Clinical Monitoring and Computing, 2018, 32 : 471 - 479
  • [36] Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease
    Yan-Hua Lai
    Wei-Dong Duan
    Qiang Yu
    Sheng Ye
    Nian-Jun Xiao
    Dong-Xin Zhang
    Zhi-Qiang Huang
    Zhan-Yu Yang
    Jia-Hong Dong
    World Journal of Gastroenterology, 2015, (20) : 6296 - 6303
  • [37] Liver Transplantation for Hepatocellular Carcinoma in the Model for End-Stage Liver Disease Era
    Levi, David M.
    Tzakis, Andreas G.
    Martin, Paul
    Nishida, Seigo
    Island, Eddie
    Moon, Jang
    Selvaggi, Gennaro
    Tekin, Akin
    Madrazo, Beatrice L.
    Narayanan, Govindarajan
    Garcia, Monica T.
    Feun, Lynn G.
    Tryphonopoulos, Panagiotis
    Skartsis, Nikolaos
    Livingstone, Alan S.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010, 210 (05) : 727 - 734
  • [38] High-dose hydroxocobalamin in end-stage liver disease and liver transplantation
    Sakpal, Sujit Vijay
    Reedstrom, Hannah
    Ness, Cody
    Klinkhammer, Tobin
    Saucedo-Crespo, Hector
    Auvenshine, Christopher
    Santella, Robert N.
    Steers, Jeffery
    DRUGS & THERAPY PERSPECTIVES, 2019, 35 (09) : 442 - 446
  • [39] Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease
    Lai, Yan-Hua
    Duan, Wei-Dong
    Yu, Qiang
    Ye, Sheng
    Xiao, Nian-Jun
    Zhang, Dong-Xin
    Huang, Zhi-Qiang
    Yang, Zhan-Yu
    Dong, Jia-Hong
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (20) : 6296 - 6303
  • [40] The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients
    Barshes, NR
    Lee, TC
    Udell, IW
    O'Mahoney, CA
    Karpen, SJ
    Carter, BA
    Goss, JA
    LIVER TRANSPLANTATION, 2006, 12 (03) : 475 - 480